Related Experiment Video

Updated: Jul 16, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

[Study on the molecular mechanism of endostatin and doxycycline in suppressing melanoma growth]

Bao-cun Sun1, Shi-wu Zhang, Li-sha Qi

  • 1Department of Pathology, Tianjin Medical University Cancer Hospital, Tianjin 300070, China. baocunsun@eyou.com

Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|March 22, 2007
PubMed
Abstract

Insights

Endostatin and doxycycline inhibit melanoma growth by altering matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) expression. This study reveals their combined potential in melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Context:

  • Melanoma is an aggressive skin cancer with limited treatment options.
  • Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play crucial roles in tumor growth and metastasis.
  • Endostatin and doxycycline are known for their anti-angiogenic and anti-inflammatory properties, respectively.

Purpose:

  • To elucidate the molecular mechanisms underlying the anti-melanoma effects of endostatin and doxycycline.
  • To investigate the impact of endostatin and doxycycline, alone and in combination, on B16 melanoma growth in a murine model.
  • To analyze the expression levels of MMP-2, MMP-9, and TIMP-2 in response to these treatments.

Summary:

  • A B16 melanoma mouse model was utilized to assess the antitumor efficacy of endostatin, doxycycline, and their combination.
  • Tumor volume was monitored over time, and immunohistochemistry was employed to evaluate the expression of MMP-2, MMP-9, and TIMP-2.
  • Both endostatin and doxycycline demonstrated significant inhibition of melanoma growth, with notable alterations in MMP and TIMP expression profiles.

Impact:

  • This research provides insights into the molecular pathways targeted by endostatin and doxycycline in melanoma.
  • The findings suggest a potential therapeutic strategy combining endostatin and doxycycline for enhanced melanoma treatment.
  • Understanding the modulation of MMPs and TIMPs by these agents could lead to the development of novel anti-melanoma therapies.

More Related Videos

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...